The use of conformation‐specific ligands and assays to dissect the molecular mechanisms of neurodegenerative diseases

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of Neuroscience Research

• Publication date

  2007-08-15

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1002/jnr.21353PMID 17497676
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics

  2009cited by this paper
• Alzheimer's disease

  2006cited by this paper
• Protein misfolding, functional amyloid, and human disease.

  2006cited by this paper
• General structural motifs of amyloid protofilaments

  2006cited by this paper
• A specific amyloid-beta protein assembly in the brain impairs memory.

  2006cited by this paper
• The Expanded Octarepeat Domain Selectively Binds Prions and Disrupts Homomeric Prion Protein Interactions*

  2006influential reference
• Probing the Conformation of the Prion Protein within a Single Amyloid Fibril Using a Novel Immunoconformational Assay*

  2006cited by this paper
• Opposing Activities Protect Against Age-Onset Proteotoxicity

  2006cited by this paper
• The alpha-to-beta conformational transition of Alzheimer's Abeta-(1-42) peptide in aqueous media is reversible: a step by step conformational analysis suggests the location of beta conformation seeding.

  2006cited by this paper
• Orally available compound prevents deficits in memory caused by the Alzheimer amyloid‐β oligomers

  2006cited by this paper
• 13C, 15N Resonance Assignment of Parts of the HET-s Prion Protein in its Amyloid Form

  2006cited by this paper
• Exogenous Induction of Cerebral ß-Amyloidogenesis Is Governed by Agent and Host

  2006cited by this paper
• The physical basis of how prion conformations determine strain phenotypes

  2006influential reference
• Molecular chaperones and protein quality control.

  2006cited by this paper
• Cyclohexanehexol inhibitors of Aβ aggregation prevent and reverse Alzheimer phenotype in a mouse model

  2006cited by this paper
• High-resolution Atomic Force Microscopy of Soluble Aβ42 Oligomers

  2006cited by this paper
• The α‐to‐β Conformational Transition of Alzheimer's Aβ‐(1–42) Peptide in Aqueous Media is Reversible: A Step by Step Conformational Analysis Suggests the Location of β Conformation Seeding

  2006influential reference
• High-resolution atomic force microscopy of soluble Abeta42 oligomers.

  2006cited by this paper
• Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice

  2006cited by this paper
• Cell-free formation of misfolded prion protein with authentic prion infectivity

  2006influential reference
• The amyloid precursor protein: beyond amyloid

  2006cited by this paper
• Recent atomic models of amyloid fibril structure.

  2006cited by this paper
• Loss of autophagy in the central nervous system causes neurodegeneration in mice

  2006cited by this paper
• A specific amyloid-β protein assembly in the brain impairs memory

  2006influential reference
• Drusen deposits associated with aging and age-related macular degeneration contain nonfibrillar amyloid oligomers.

  2006cited by this paper
• Continuum of prion protein structures enciphers a multitude of prion isolate-specified phenotypes

  2006cited by this paper
• Prefibrillar Amyloid Aggregates Could Be Generic Toxins in Higher Organisms

  2006cited by this paper
• Different Conformations of Amyloid β Induce Neurotoxicity by Distinct Mechanisms in Human Cortical Neurons

  2006cited by this paper
• Stability of HAMLET—A kinetically trapped α‐lactalbumin oleic acid complex

  2005cited by this paper
• Amyloid β protein immunotherapy neutralizes Aβ oligomers that disrupt synaptic plasticity in vivo

  2005influential reference
• Functional Amyloid Formation within Mammalian Tissue

  2005cited by this paper
• 3D structure of Alzheimer's amyloid-β(1–42) fibrils

  2005cited by this paper
• Globular amyloid β‐peptide1−42 oligomer − a homogenous and stable neuropathological protein in Alzheimer's disease

  2005cited by this paper
• Correlation of structural elements and infectivity of the HET-s prion

  2005cited by this paper
• Fine structure study of Aβ1–42 fibrillogenesis with atomic force microscopy

  2005cited by this paper
• Conversion of a-helices into ,f-sheets features in the formation of the scrapie prion proteins

  2005cited by this paper
• Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease.

  2005cited by this paper
• Amyloid beta protein immunotherapy neutralizes Abeta oligomers that disrupt synaptic plasticity in vivo.

  2005cited by this paper
• Synaptic plasticity disruption by amyloid beta protein: modulation by potential Alzheimer's disease modifying therapies.

  2005cited by this paper
• In vitro generation of infectious scrapie prions.

  2005influential reference
• Natural oligomers of the amyloid-β protein specifically disrupt cognitive function

  2005cited by this paper
• Intrinsically unstructured proteins and their functions

  2005cited by this paper
• Modelling the actions of chaperones and their role in ageing.

  2005cited by this paper
• The role of cell-derived oligomers of Abeta in Alzheimer's disease and avenues for therapeutic intervention.

  2005cited by this paper
• 3D structure of Alzheimer's amyloid-beta(1-42) fibrils.

  2005cited by this paper
• Cyclic amplification of protein misfolding and aggregation.

  2005cited by this paper
• Search for a Prion-Specific Nucleic Acid

  2005cited by this paper
• Structure of the cross-beta spine of amyloid-like fibrils.

  2005influential reference
• Synthetic Mammalian Prions

  2004cited by this paper
• RNA interference of valosin-containing protein (VCP/p97) reveals multiple cellular roles linked to ubiquitin/proteasome-dependent proteolysis

  2004cited by this paper
• Conformational variations in an infectious protein determine prion strain differences

  2004cited by this paper
• NMR structure of the bovine prion protein isolated from healthy calf brains

  2004cited by this paper
• Metabolite-initiated protein misfolding may trigger Alzheimer's disease.

  2004cited by this paper
• 7 Prions of Yeast and Filamentous Fungi: [URE3], [ PSI + ], [ PIN + ], and [Het-s]

  2004cited by this paper
• Natively unfolded domains in endocytosis: hooks, lines and linkers

  2004cited by this paper
• Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution

  2003cited by this paper
• Abbreviated incubation times for human prions in mice expressing a chimeric mouse–human prion protein transgene

  2003cited by this paper
• Regulation of Aging and Age-Related Disease by DAF-16 and Heat-Shock Factor

  2003cited by this paper
• Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis

  2003influential reference
• Amyloid -protein (A) assembly: A40 and A42 oligomerize through distinct pathways

  2003cited by this paper
• A prion protein epitope selective for the pathologically misfolded conformation

  2003cited by this paper
• Epitope and isotype specificities of antibodies to β-amyloid peptide for protection against Alzheimer's disease-like neuropathology

  2003cited by this paper
• A neuronal isoform of the aplysia CPEB has prion-like properties.

  2003cited by this paper
• Intrinsically unstructured proteins evolve by repeat expansion

  2003cited by this paper
• Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders.

  2003cited by this paper
• IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice

  2003cited by this paper
• Amyloid beta -protein (Abeta) assembly: Abeta 40 and Abeta 42 oligomerize through distinct pathways.

  2003cited by this paper
• Toxic Proteins in Neurodegenerative Disease

  2002cited by this paper
• Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases

  2002cited by this paper
• A change in the conformation of prions accompanies the emergence of a new prion strain.

  2002cited by this paper
• Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo

  2002cited by this paper
• Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: The emerging role of oligomeric assemblies

  2002cited by this paper
• Conformational Abs recognizing a generic amyloid fibril epitope

  2002cited by this paper
• The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics

  2002cited by this paper
• Conformational control through translocational regulation: a new view of secretory and membrane protein folding.

  2002cited by this paper
• The protofilament structure of insulin amyloid fibrils

  2002cited by this paper
• Generation of antibodies specific for β-amyloid by vaccination of patients with Alzheimer disease

  2002cited by this paper
• Alzheimer's disease: genes, proteins, and therapy.

  2001cited by this paper
• Strain‐specified relative conformational stability of the scrapie prion protein

  2001cited by this paper
• Shattuck lecture--neurodegenerative diseases and prions.

  2001cited by this paper
• Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding

  2001cited by this paper
• Conformational diversity in a yeast prion dictates its seeding specificity

  2001cited by this paper
• Inositol stereoisomers stabilize an oligomeric aggregate of Alzheimer amyloid beta peptide and inhibit abeta -induced toxicity.

  2000cited by this paper
• [Prions in yeast and filamentous fungi].

  2000cited by this paper
• Evidence for the prion hypothesis: induction of the yeast [PSI+] factor by in vitro- converted Sup35 protein.

  2000cited by this paper
• Conversion of alpha-lactalbumin to a protein inducing apoptosis.

  2000cited by this paper
• Inositol Stereoisomers Stabilize an Oligomeric Aggregate of Alzheimer Amyloid β Peptide and Inhibit Aβ-induced Toxicity*

  2000influential reference
• Transmissible and genetic prion diseases share a common pathway of neurodegeneration

  1999cited by this paper
• Staining methods for identification of amyloid in tissue.

  1999cited by this paper
• Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse

  1999cited by this paper
• Antibody binding defines a structure for an epitope that participates in the PrPC-->PrPSc conformational change.

  1999cited by this paper
• Monoclonal antibodies specific for the native, disease-associated isoform of the prion protein.

  1999cited by this paper
• Prion protein conformation in a patient with sporadic fatal insomnia.

  1999cited by this paper
• 2 Development of the Prion Concept

  1999cited by this paper
• Eight prion strains have PrPSc molecules with different conformations

  1998cited by this paper
• Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins.

  1998cited by this paper
• A transmembrane form of the prion protein in neurodegenerative disease.

  1998influential reference
• Phosphatidylinositol and inositol involvement in Alzheimer amyloid-beta fibril growth and arrest.

  1998cited by this paper
• Recombinant full‐length murine prion protein, mPrP(23–231): purification and spectroscopic characterization

  1997cited by this paper
• Alpha-synuclein in Lewy bodies.

  1997cited by this paper

• A pan-respiratory antiviral chemotype targeting a transient host multi-protein complex

  2024cites this paper
• Conformation-dependent anti-Aβ monoclonal antibody signatures of disease status and severity in urine of women with preeclampsia.

  2022cites this paper
• A Pan-Respiratory Antiviral Chemotype Targeting a Host Multi-Protein Complex

  2021cites this paper
• Selektion und Charakterisierung von Bindeproteinenfür amyloidogene Peptide und Proteine

  2021cites this paper
• A Generic Method for Design of Oligomer-Specific Antibodies

  2014cites this paper
• Hybrid molecules synergistically acting against protein aggregation diseases.

  2013cites this paper
• A Visual Dual-Aptamer Logic Gate for Sensitive Discrimination of Prion Diseases-Associated Isoform with Reusable Magnetic Microparticles and Fluorescence Quantum Dots

  2013cites this paper
• Vaccine Approaches to Prevent and Treat Prion Infection

  2012cites this paper
• Computational modeling of the relationship between amyloid and disease

  2012cites this paper
• Dual role of Cu²⁺ ions on the aggregation and degradation of soluble Aβ oligomers and protofibrils investigated by fluorescence spectroscopy and AFM.

  2012cites this paper
• Aggregates with lysozyme and ovalbumin show features of amyloid-like fibrils.

  2011cites this paper
• A b 40 Oligomers Identified as a Potential Biomarker for the Diagnosis of Alzheimer ’ s Disease

  2011cites this paper
• A universal method for detection of amyloidogenic misfolded proteins.

  2011cites this paper
• Sensitive discrimination and detection of prion disease-associated isoform with a dual-aptamer strategy by developing a sandwich structure of magnetic microparticles and quantum dots.

  2010cites this paper
• Triazole-containing BODIPY dyes as novel fluorescent probes for soluble oligomers of amyloid Abeta1-42 peptide.

  2010cites this paper
• A beta 40 Oligomers Identified as a Potential Biomarker for the Diagnosis of Alzheimer ' s Disease

  2010cites this paper
• Ab40 Oligomers Identified as a Potential Biomarker for the Diagnosis of Alzheimer’s Disease

  2010cites this paper
• Aβ40 Oligomers Identified as a Potential Biomarker for the Diagnosis of Alzheimer's Disease

  2010cites this paper
• Medicinal inorganic chemistry approaches to passivation and removal of aberrant metal ions in disease.

  2009cites this paper
• Complementarity determining regions of an anti-prion protein scFv fragment orchestrate conformation specificity and antiprion activity.

  2009cites this paper
• Fluorescent BODIPY-based Zn(II) complex as a molecular probe for selective detection of neurofibrillary tangles in the brains of Alzheimer's disease patients.

  2009cites this paper
• Translational medicine perspective in development of disease modifying therapies for Alzheimer's disease: biomarkers to buy down the risk

  2009cites this paper
• Mallory-Denk-bodies: lessons from keratin-containing hepatic inclusion bodies.

  2008cites this paper